NASDAQ:EKSO Ekso Bionics (EKSO) Stock Forecast, Price & News $0.69 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.66▼$0.7550-Day Range$0.69▼$1.3852-Week Range$0.62▼$1.88Volume68,063 shsAverage Volume59,532 shsMarket Capitalization$9.53 millionP/E RatioN/ADividend YieldN/APrice Target$9.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Ekso Bionics MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,204.3% Upside$9.00 Price TargetShort InterestHealthy0.32% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 2 Articles This WeekInsider TradingSelling Shares$50,230 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.29) to ($0.87) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.01 out of 5 stars 3.5 Analyst's Opinion Consensus RatingEkso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.00, Ekso Bionics has a forecasted upside of 1,204.3% from its current price of $0.69.Amount of Analyst CoverageEkso Bionics has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.32% of the float of Ekso Bionics has been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently increased by 32.72%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEkso Bionics does not currently pay a dividend.Dividend GrowthEkso Bionics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EKSO. Previous Next 1.3 News and Social Media Coverage News SentimentEkso Bionics has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Ekso Bionics this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ekso Bionics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $50,230.00 in company stock.Percentage Held by InsidersOnly 7.50% of the stock of Ekso Bionics is held by insiders.Percentage Held by InstitutionsOnly 9.54% of the stock of Ekso Bionics is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Ekso Bionics are expected to grow in the coming year, from ($1.29) to ($0.87) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ekso Bionics is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ekso Bionics is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEkso Bionics has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Ekso Bionics (NASDAQ:EKSO) StockEkso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.Read More EKSO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EKSO Stock News HeadlinesSeptember 22, 2023 | seekingalpha.comEKSO Ekso Bionics Holdings, Inc.September 21, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Ekso Bionics (NASDAQ:EKSO)September 23, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.September 16, 2023 | americanbankingnews.comEkso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest UpdateSeptember 14, 2023 | americanbankingnews.comEkso Bionics (NASDAQ:EKSO) Receives New Coverage from Analysts at StockNews.comSeptember 11, 2023 | finance.yahoo.comEkso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 9, 2023 | benzinga.comEkso Bionics Holdings Stock (NASDAQ:EKSO) Dividends: History, Yield and DatesAugust 25, 2023 | benzinga.comBionic Devices market is projected to grow at a CAGR of 9.5% by 2033: VisiongainSeptember 23, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.July 28, 2023 | seekingalpha.comEkso Bionics Holdings, Inc. (EKSO) Q2 2023 Earnings Call TranscriptJuly 28, 2023 | finanznachrichten.deEkso Bionics Holdings, Inc.: Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023July 28, 2023 | msn.comEkso Bionics Holdings GAAP EPS of -$0.31 misses by $0.03, revenue of $4.7M beats by $0.35MJuly 28, 2023 | finance.yahoo.comEkso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023July 28, 2023 | finance.yahoo.comQ2 2023 Ekso Bionics Holdings Inc Earnings CallJuly 20, 2023 | finance.yahoo.comEkso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023July 14, 2023 | au.finance.yahoo.comEKSO - Ekso Bionics Holdings, Inc.May 15, 2023 | marketwatch.comHealthcare Assistive Robot Market Expected Growth, Demand and Trends for 2030 | Barrett Technology, Cyberdyne, Ekso BionicsMay 11, 2023 | marketwatch.comHuman Augmentation Market Report Covers Future Trends with Research 2023-2029 | B-Temia, BrainGate, Ekso BionicsMay 10, 2023 | marketwatch.comLower Limb Rehabilitation Robot Market Demand and Value Forecast 2023-2029 – AlterG, Bionik, Ekso Bionics, MyomoMay 9, 2023 | marketwatch.comRehabilitation Robotics Market 2023-2031: Analyzing Growth Opportunities and ChallengesMay 3, 2023 | marketwatch.comWith CAGR of 3% South Africa Artificial Organs & Bionic Implants Market Size and Updated Report 2023-2031May 2, 2023 | marketwatch.com2023-2030 Soft Robotics Market Future Scope and Growth ProspectsMay 2, 2023 | marketwatch.comInflatable Soft Robotic Market Demand Analysis, Sales and Forecast 2023-2029 – Cyberdyne Inc., Ekso Bionics, FANUC CORPORATION, FRANKA EMIKA GmbHApril 29, 2023 | marketwatch.comGlobal "Exoskeleton Robots Market" Booming Opportunities in near Future 2023 to 2031April 29, 2023 | msn.comHC Wainwright & Co. Reiterates Ekso Bionics Holdings (EKSO) Buy RecommendationApril 28, 2023 | marketwatch.comMedical Bionic Implant Artificial Organs Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030April 28, 2023 | finanznachrichten.deEkso Bionics Holdings, Inc.: Ekso Bionics Announces 61% Increase in First Quarter 2023 RevenuesSee More Headlines Receive EKSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address EKSO Company Calendar Last Earnings7/27/2023Today9/23/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry General industrial machinery, Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EKSO Previous SymbolOTCMKTS:EKSOD CUSIPN/A CIK1549084 Webwww.eksobionics.com Phone(510) 984-1761Fax510-927-2647Employees72Year FoundedN/APrice Target and Rating Average Stock Price Forecast$9.00 High Stock Price Forecast$9.00 Low Stock Price Forecast$9.00 Forecasted Upside/Downside+1,204.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,080,000.00 Net Margins-102.52% Pretax Margin-102.52% Return on Equity-69.14% Return on Assets-42.57% Debt Debt-to-Equity Ratio0.19 Current Ratio2.44 Quick Ratio1.89 Sales & Book Value Annual Sales$15.71 million Price / Sales0.61 Cash FlowN/A Price / Cash FlowN/A Book Value$1.94 per share Price / Book0.36Miscellaneous Outstanding Shares13,807,000Free Float12,771,000Market Cap$9.53 million OptionableNot Optionable Beta1.75 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Scott G. Davis (Age 53)CEO & Director Comp: $535.8kMr. Jerome Wong (Age 49)Corp. Controller, Corp. Sec. & CFO Comp: $356.81kMr. Jason C. JonesChief Operating OfficerMs. Rachael AndersonGlobal Director of Marketing & Strategic GrowthMr. Anthony PrattVP of SalesMs. Ann CooksonHR DirectorMs. Foon Lim ChweePres of APACMr. Stephan AderholdSr. VP & GM of EMEAMore ExecutivesKey CompetitorsShuttle PharmaceuticalsNASDAQ:SHPHTimber PharmaceuticalsNYSE:TMBRVaccinexNASDAQ:VCNXImunonNASDAQ:IMNNAlterity TherapeuticsNASDAQ:ATHEView All CompetitorsInsiders & InstitutionsScott G DavisSold 37,446 sharesTotal: $37,446.00 ($1.00/share)Jerome WongSold 12,784 sharesTotal: $12,784.00 ($1.00/share)Citadel Advisors LLCSold 400 shares on 8/15/2023Ownership: 0.000%Simplex Trading LLCSold 100 shares on 8/4/2023Ownership: 0.000%Steven ShermanSold 45,660 sharesTotal: $65,750.40 ($1.44/share)View All Insider TransactionsView All Institutional Transactions EKSO Stock - Frequently Asked Questions Should I buy or sell Ekso Bionics stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EKSO shares. View EKSO analyst ratings or view top-rated stocks. What is Ekso Bionics' stock price forecast for 2023? 1 Wall Street research analysts have issued 1 year target prices for Ekso Bionics' stock. Their EKSO share price forecasts range from $9.00 to $9.00. On average, they predict the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 1,204.3% from the stock's current price. View analysts price targets for EKSO or view top-rated stocks among Wall Street analysts. How have EKSO shares performed in 2023? Ekso Bionics' stock was trading at $1.19 at the beginning of the year. Since then, EKSO shares have decreased by 42.0% and is now trading at $0.69. View the best growth stocks for 2023 here. Are investors shorting Ekso Bionics? Ekso Bionics saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 36,100 shares, an increase of 32.7% from the August 15th total of 27,200 shares. Based on an average daily trading volume, of 51,700 shares, the short-interest ratio is currently 0.7 days. Approximately 0.3% of the shares of the company are short sold. View Ekso Bionics' Short Interest. When is Ekso Bionics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our EKSO earnings forecast. How were Ekso Bionics' earnings last quarter? Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) released its quarterly earnings results on Thursday, July, 27th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.03. The company had revenue of $4.70 million for the quarter, compared to analyst estimates of $4.35 million. Ekso Bionics had a negative net margin of 102.52% and a negative trailing twelve-month return on equity of 69.14%. When did Ekso Bionics' stock split? Ekso Bionics shares reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. What other stocks do shareholders of Ekso Bionics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include Organigram (OGI), Gran Tierra Energy (GTE), KushCo (KSHB), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and ADMA Biologics (ADMA). What is Ekso Bionics' stock symbol? Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO." Who are Ekso Bionics' major shareholders? Ekso Bionics' stock is owned by a number of retail and institutional investors. Top institutional investors include Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Jason C Jones, Jerome Wong, John Glenn, Scott G Davis and Steven Sherman. View institutional ownership trends. How do I buy shares of Ekso Bionics? Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ekso Bionics' stock price today? One share of EKSO stock can currently be purchased for approximately $0.69. How much money does Ekso Bionics make? Ekso Bionics (NASDAQ:EKSO) has a market capitalization of $9.53 million and generates $15.71 million in revenue each year. The company earns $-15,080,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. How can I contact Ekso Bionics? Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The official website for the company is www.eksobionics.com. The company can be reached via phone at (510) 984-1761, via email at investors@eksobionics.com, or via fax at 510-927-2647. This page (NASDAQ:EKSO) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.